Spectral AI’s DeepView® System Showcased at 2026 American Burn Association Annual Meeting
Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today shared a recap from the 2026 Annual Meeting of the American Burn Association, held April 14-17, 2026 in Orlando, Florida.
The theme of this year’s conference, Leading Burn Care into Tomorrow, provided a rich and relevant platform for U.S. and UK clinicians to present various aspects of the DeepView System® to more than 2,200 clinicians, researchers, and burn care leaders from across the globe.
The DeepView System is an AI-driven, predictive diagnostic device and associated software platform that combines multispectral imaging with a proprietary AI algorithm to assess the healing potential of burn wounds. The DeepView System provides clinicians with an immediate, data-driven assessment of whether a burn wound will heal on its own or requires significant medical intervention, enabling earlier and more informed treatment decisions. Spectral AI submitted its De Novo 510(k) marketing clearance application for the DeepView System to the U.S. Food and Drug Administration (FDA) in June 2025.
Dr. Christopher J. Lewis FRCS (Plast) presented an overview of the DeepView System, including real world experience, to attendees at the ABA Innovation Theater on April 14, 2026. Dr. Lewis is a Consultant Plastic, Burn & Reconstructive Surgeon working within the NHS at the Royal Victoria Infirmary, Newcastle upon Tyne in the United Kingdom. As part of Mr. Lewis’ podium presentation he noted: “DeepView provides a high-quality image that supports conventional assessment rather than replacing it. Acquisition is fast, non-contact, and practical in the real-world burns setting and usability for surgeons, nurses, and patients appears to be a major strength.”
The DeepView System was prominent in a number of podium and poster presentations. “Our presence at ABA 2026 reinforces our commitment to advancing scientific understanding and sharing meaningful data with the broader burn community,” said Vincent Capone, Chief Executive Officer. “We believe that the DeepView System can help redefine the assessment and treatment of burn wounds, while democratizing care for all patients.”
Write to us [wasim.a@demandmediaagency.com] to learn more about our exclusive editorial packages and programmes.
